News Stories

Register for the NLA Annual Business Meeting by clicking here. 

Join us on Monday, June 8 from 6:00 – 6:30 PM ET for the NLA’s Annual Business Meeting for important NLA updates and award announcements:

Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C.

MINNEAPOLIS, MN – (Sept. 14, 2019) – A comprehensive review of scientific evidence that analyzes the impact of low-carbohydrate and very-low-carbohydrate diets (including ketogenic diets) on cardiometabolic risk factors and body weight was released today by the National Lipid Association (NLA).